is retatrutide approved in other countries UK 2026: Phase 3 Results Retatrutide, an experimental weight-loss drug,

Serafini G

First, GLP-1RAs have been shown to inhibit the expression and release of proinflammatory cytokines, such as IL-6 and TNF-, thereby inhibiting the overall inflammatory response

This was a double-blind study, meaning neither the researchers nor the patients knew which treatment they were receiving

doi:10.1530/eje.0.1460863 Lee S, Lee DY

Clinically reviewed by Mohammed Ismail Lakhi, MPharm, MRPharmS, Superintendent Pharmacist (GPhC reg

A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association